Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthopediatrics (KIDS) Receivables (2016 - 2025)

Orthopediatrics has reported Receivables over the past 10 years, most recently at $55.1 million for Q4 2025.

  • Quarterly results put Receivables at $55.1 million for Q4 2025, up 26.33% from a year ago — trailing twelve months through Dec 2025 was $55.1 million (up 26.33% YoY), and the annual figure for FY2025 was $55.1 million, up 26.33%.
  • Receivables for Q4 2025 was $55.1 million at Orthopediatrics, up from $51.3 million in the prior quarter.
  • Over the last five years, Receivables for KIDS hit a ceiling of $55.1 million in Q4 2025 and a floor of $16.6 million in Q1 2021.
  • Median Receivables over the past 5 years was $34.9 million (2023), compared with a mean of $33.8 million.
  • Biggest five-year swings in Receivables: grew 3.95% in 2021 and later surged 51.18% in 2022.
  • Orthopediatrics' Receivables stood at $19.2 million in 2021, then skyrocketed by 35.73% to $26.0 million in 2022, then soared by 37.69% to $35.9 million in 2023, then grew by 21.58% to $43.6 million in 2024, then grew by 26.33% to $55.1 million in 2025.
  • The last three reported values for Receivables were $55.1 million (Q4 2025), $51.3 million (Q3 2025), and $53.8 million (Q2 2025) per Business Quant data.